Loading…
Surgery Partners, Inc. is projected to rise to $19.52 by 2027, a +16% move from its current price of $16.77. SGRY is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $16.42 | $16.77 | $17.13 | +0.01% |
| Jul 14 | $16.28 | $16.77 | $17.28 | +0.01% |
| Jul 15 | $16.17 | $16.77 | $17.40 | +0.02% |
| Jul 16 | $16.08 | $16.77 | $17.50 | +0.03% |
| Jul 17 | $16.00 | $16.78 | $17.59 | +0.03% |
| Jul 18 | $15.92 | $16.78 | $17.67 | +0.04% |
| Jul 19 | $15.86 | $16.78 | $17.75 | +0.05% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $15.86 | $16.78 | $17.75 | +0.05% |
| Week 2 | $15.50 | $16.79 | $18.18 | +0.10% |
| Week 3 | $15.23 | $16.79 | $18.51 | +0.14% |
| Week 4 | $15.01 | $16.80 | $18.81 | +0.19% |
| Week 5 | $14.82 | $16.81 | $19.07 | +0.24% |
| Week 6 | $14.65 | $16.82 | $19.31 | +0.29% |
| Week 7 | $14.50 | $16.83 | $19.53 | +0.34% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Surgery Partners, Inc. owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in a range of specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.
It offers emergency departments; ancillary services such as physician practices and diagnostic testing; multi-specialty physician practices; urgent care facilities; and anesthesia services. The company has single- and multi-specialty facilities and was founded in 2004 and is headquartered in Brentwood, Tennessee.
Surgery Partners (SGRY) is currently priced at $16.56 and has a market capitalization of $2.07B, ranking 5458 by market size. The price outlook, based on the provided forecasts, shows a path of rising values after 2026, with the 2026 average equal to the current price and higher averages projected in later years. In 2027 the average is forecast at $19.45, rising to $24.96 by 2030, $62.52 by 2040, and $126.94 by 2050, with progressively higher max values and bullish sentiment in the longer term.
A major floor 31.5% below — a decisive break under it would weaken the trend.
The nearest floor, 21.2% below — buyers have tended to step in here.
Price is pressing into resistance (2.7% away) — a breakout level to watch.
A major ceiling 17.0% above — clearing it would confirm fresh momentum.
Key SGRY support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of SGRY market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $16.77 | Buy | $16.64 | Buy |
| MA 10 | $16.68 | Buy | $16.45 | Buy |
| MA 20 | $15.80 | Buy | $15.89 | Buy |
| MA 50 | $14.64 | Buy | $14.99 | Buy |
| MA 100 | $14.08 | Buy | $14.88 | Buy |
| MA 200 | $15.85 | Buy | $16.13 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.46 | Neutral |
| Stoch RSI (14) | 20.96 | Neutral |
| CCI (20) | 45.31 | Neutral |
| Williams %R (14) | -30.74 | Info |
| MACD (12,26,9) | 0.04 | Buy |
| ROC (12) | 12.87 | Buy |
| Bollinger %B (20,2) | 0.66 | Neutral |
| Stochastic %K (14) | 69.26 | Neutral |
| TRIX (15) | 0.67 | Buy |
| Awesome (5,34) | 1.87 | Buy |
| Ultimate (7,14,28) | 53.39 | Neutral |
| Momentum (10) | 0.94 | Buy |
| Aroon Osc (25) | 80.00 | Buy |
| Hull MA (9) | 16.64 | Buy |
| ADX (14) | 27.97 | Buy |
| ATR (14) | 0.33 | Info |
The 30-day technical picture is bullish. RSI14 is 70, suggesting strong momentum, with a 50-day simple moving average (SMA) of $14.26 and a 200-day SMA of $16.05. Near-term support sits at $13.22 while resistance is at $16.56. The 30-day price range runs from a low of $14.30 to a high of $19.18, and annualized volatility is 40%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $11.49 | $16.77 | $21.47 | 0% | Neutral | |
| $15.86 | $19.52 | $25.22 | +16% | Neutral | |
| $16.39 | $20.61 | $27.43 | +23% | Bullish | |
| $17.34 | $22.18 | $30.22 | +32% | Bullish | |
| $19.11 | $24.83 | $34.50 | +48% | Bullish | |
| $23.10 | $30.44 | $43.03 | +82% | Bullish | |
| $26.10 | $34.84 | $50.03 | +108% | Bullish | |
| $25.90 | $34.98 | $50.95 | +109% | Bullish | |
| $27.56 | $37.65 | $55.57 | +125% | Bullish | |
| $29.63 | $40.93 | $61.15 | +144% | Bullish | |
| $43.38 | $62.92 | $98.95 | +275% | Bullish | |
| $81.37 | $128.10 | $217.33 | +664% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $11.49 | $16.77 | $20.25 | +0.00% |
| August 2026 | $14.67 | $17.21 | $20.67 | +2.63% |
| September 2026 | $14.30 | $16.88 | $20.44 | -1.95% |
| October 2026 | $14.27 | $16.92 | $20.64 | +0.25% |
| November 2026 | $14.58 | $17.35 | $21.31 | +2.59% |
| December 2026 | $14.56 | $17.39 | $21.47 | +0.21% |
Click any year to see its month-by-month SGRY forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The SGRY price prediction for 2026 points to an average of $16.77 (low $11.49, high $21.47) — a potential gain of 0% on today's $16.77. Price action looks broadly range-bound.
In 2027, SGRY is projected to trade between $15.86 and $25.22, averaging $19.52 — a potential gain of +16% from today's $16.77. That is up +16% on the projected 2026 average. A consolidation phase looks the most probable path here.
Surgery Partners, Inc.'s 2028 outlook centres on $20.61, within a $16.39 to $27.43 range. That is up +6% on the projected 2027 average. That marks a +23% change versus current levels. Momentum favours further upside here.
By 2029, SGRY could reach as high as $30.22, with a base case around $22.18 and support toward $17.34 — roughly +32% from $16.77. Buyers look set to stay in control over this stretch.
Expect SGRY to range from $19.11 to $34.50 through 2030. The $24.83 average target implies a +48% move from current prices. That is up +12% on the projected 2029 average. Momentum favours further upside here.
The SGRY price prediction for 2031 points to an average of $30.44 (low $23.10, high $43.03) — a potential gain of +82% on today's $16.77. Buyers look set to stay in control over this stretch.
In 2032, SGRY is projected to trade between $26.10 and $50.03, averaging $34.84 — a potential gain of +108% from today's $16.77. That is up +14% on the projected 2031 average. Momentum favours further upside here.
Surgery Partners, Inc.'s 2033 outlook centres on $34.98, within a $25.90 to $50.95 range. That is up 0% on the projected 2032 average. That marks a +109% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, SGRY could reach as high as $55.57, with a base case around $37.65 and support toward $27.56 — roughly +125% from $16.77. Momentum favours further upside here.
Expect SGRY to range from $29.63 to $61.15 through 2035. The $40.93 average target implies a +144% move from current prices. That is up +9% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The SGRY price prediction for 2040 points to an average of $62.92 (low $43.38, high $98.95) — a potential gain of +275% on today's $16.77. Momentum favours further upside here.
In 2050, SGRY is projected to trade between $81.37 and $217.33, averaging $128.10 — a potential gain of +664% from today's $16.77. That is up +104% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in SGRY today (≈ 59.630292 SGRY) could be worth
$7,638.46
+$6,638.46 (+664%) by 2050 · US Dollar
Based on the average projected SGRY price of $128.1 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in SGRYwould be worth at today's price.
$1,000 invested in SGRY on Jul 10, 2025 (≈ 44.893379 SGRY) would be worth
$752.86
-$247.14 (-24.7%) today · 0.75× · US Dollar
Based on a SGRY entry price of $22.27 vs. today's $16.77.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $17.23 | $973.3 | -2.7% |
| 1 month ago | $14.2 | $1,180.99 | +18.1% |
| 3 months ago | $12.91 | $1,298.99 | +29.9% |
| 6 months ago | $16.28 | $1,030.1 | +3.0% |
| 1 year ago | $22.27 | $752.86 | -24.7% |
| All time (5.0y) ago | $62.04 | $270.31 | -73.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our SGRY forecast.
Our base-case forecast reaches $34.00 around 2032.
Implied market cap at $34.00: $4.45B
The multi-year forecast shows a pronounced rise in the average price and bullish sentiment from 2027 onward. The 2030 forecast gives an average price of $24.96 with a reported ROI of 50.7 and bullish sentiment. The 2040 forecast projects an average of $62.52 with ROI of 277.5 and bullish sentiment, and the 2050 forecast shows an average of $126.94 with ROI of 666.6 and bullish sentiment.
Earlier years include 2026 with an average of $16.56 (neutral) and 2027 at $19.45 (neutral), with continuing gains into the late 2020s and 2030s. These figures are estimates and not guarantees, reflecting potential upside under the given assumptions.
Tap a question to reveal the answer.
The forecast for 2030 shows an average price of $24.96, a min of $19.08, a max of $34.98, with an ROI of 50.7 and bullish sentiment.
Forecasts indicate rising average prices from 2027 onward and bullish sentiment into 2030, 2040, and 2050, with ROI values of 50.7 (2030), 277.5 (2040), and 666.6 (2050). Note that 2026 is neutral, and these are estimates, not guarantees.
In 2040 the max forecast is $99.59, which is just under 100, but by 2050 the max forecast is $218.68, indicating that a price above 100 is possible in the longer term.
Current price: $16.56. Market cap: $2.07B.
The 30-day range is $14.30 to $19.18. RSI14 is 70, SMA50 is $14.26, SMA200 is $16.05. Support is $13.22 and resistance is $16.56, with annualized volatility at 40%.
Surgery Partners, Inc. Community Discussion
0Share your Surgery Partners, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.